Retatrutide is just the start of a new generation of multi-agonist treatments aimed at addressing obesity, metabolic disease, and even cardiovascular health ushering in a true metabolic medicine revolution.
Thompson, A., & Trujillo, J
It mainly stimulates insulin secretion and inhibits the release of glucagon by binding to receptors on pancreatic beta cells, thus helping to lower blood glucose levels
There are three recommended semaglutide injection sites, which include: The Abdomen or Stomach The most common and convenient area for injecting semaglutide is the abdomen
Consult a doctor for evaluation and replacement options
The difference is that Mounjaro is manufactured by Eli Lilly as a branded product, while compounded tirzepatide is prepared by FDA-registered compounding pharmacies